Table 6.
Author, Year | No of Studies (TNs) |
RSSs | Sensitivity Pooled (CI-95) |
Specificity Pooled (CI-95) |
LHR+ Pooled (CI-95) |
LHR- Pooled (CI-95) |
DOR Pooled (CI-95) |
AUC on ROC |
---|---|---|---|---|---|---|---|---|
Wei et al., 2016 [39] |
12 (10,437) |
mixed | 0.79 | 0.71 | 6.62 | 0.2 | 35.2 | 0.918 |
TIRADS | (0.77–0.81) | (0.70–0.72) | (4.39–9.99) | (0.14–0.29) | (19.5–63.4) | |||
Migda et al., 2018 [40] |
6 (10,926) |
Kwak | 0.98 | 0.55 | 2.67 | 0.05 | 51 | 0.938 |
(0.98–0.99) | (0.54–0.56) | (1.69–4.20) | (0.04–0.07) | (15.2–170.8) | ||||
Kim et al., 2020 [41] |
29 (33,748) | ACR | 0.66 | 0.91 | 0.89 | |||
(0.56–0.75) | (0.87–0.94) | |||||||
ATA | 0.74 | 0.88 | 0.9 | |||||
(0.62–0.84) | (0.82–0.93) | |||||||
Korean | 0.55 | 0.95 | 0.88 | |||||
(0.38–0.70) | (0.90–0.98) | |||||||
EU | 0.82 | 0.9 | 0.91 | |||||
(0.71–0.89) | (0.77–0.96) | |||||||
Kim et al., 2020 [42] |
34 (37,585) |
ACR | 0.7 | 0.89 | ||||
(0.61–0.79) | (0.85–0.92) | |||||||
Korean | 0.64 | 0.93 | ||||||
(0.58–0.70) | (0.91–0.95) | |||||||
EU | 0.78 | 0.89 | ||||||
(0.64–0.88) | (0.77–95) | |||||||
Castellana et al., 2020 [43] |
12 (18,750) |
ACR | 0.74 | 0.64 | 1.9 | 0.4 | 4.9 | |
(0.61–0.83) | (0.56–0.70) | (1.6–2.3) | (0.3–0.6) | (3.1–7.7) | ||||
ATA | 0.87 | 0.31 | 1.2 | 0.4 | 3.1 | |||
(0.75–0.94) | (0.24–0.40) | (1.0–1.4) | (0.2–0.7) | (1.3–7.1) | ||||
EU | 0.54 | 0.53 | 1.4 | 0.6 | 2.2 | |||
(0.51–0.57) | (0.51–0.55) | (1.0–1.8) | (0.4–1.0) | (0.9–5.1) | ||||
Korean | 0.86 | 0.28 | 1.2 | 0.5 | 2.5 | |||
(0.73–0.94) | (0.20–0.38) | (1.0–1.4) | (0.2–1.0) | (1.1–5.5) |
Abbreviations: RSSs—Risk Stratification Systems; TNs—Thyroid Nodules; LHR+—Positive Likelihood Ratio; LHR-—Negative Likelihood Ratio; DOR—Diagnostic Odds Ratio; AUC—Area Under The Curve; ROC—Receiver Operating Curves; CI-95—95% Confidence Intervals; TIRADS—Thyroid Imaging Reporting and Data System; ACR—American College of Radiology; EU—European Union; ATA—American Thyroid Association.